Deadly Bacteria Invades Communities—MRSA Infections Jump 55 Percent; Clearstream, LLC Calls for Advanced Sanitization Methods to Contain Public Health Threat

Officials at Clearstream, LLC, who previously spoke out about MRSA’s prevalence in athletic facilities, are now warning of the infection’s spread to communities. In order to prevent what is now a growing public health threat, Clearstream is advancing the first antimicrobial technology that actively provides long-term protection without the use of harmful poisons.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Through our technology, we aim to eradicate harmful microorganisms and protect the surfaces that human populations come in contact with, thereby providing an additional safeguard for the public.

Harrisburg, NC (PRWEB) April 16, 2014

Historically, MRSA infections were relegated to sick patients in hospitals and healthcare facilities, but the ever-resistant bacteria is now present within communities and increasingly infecting otherwise healthy children and adults. In a 2013 report released by the Centers for Disease Control (CDC), researchers established a 10 percent per year rise in MRSA infections in kids from 2005-2010, and the proportion of those cases involving community-associated MRSA jumped by 55 percent (1). Clearstream, LLC, a diversified provider of environmentally-friendly antimicrobial products and services, says that the serious risks posed by MRSA infections make advanced sanitization technology and hygiene methods essential to protecting public health. Clearstream utilizes sophisticated antimicrobial technologies and advanced long-term application protocols throughout the U.S. in an effort to stop the spread of viral and bacterial contaminants.

MRSA can cause skin and soft tissue infections, but this “superbug” can also lead to more serious illnesses, including bloodstream infections and pneumonia—and the antibiotic-resistant bacteria has the ability to render healthy individuals severely ill within hours:

●    39-year-old Eric Allen went to the hospital after coughing up lung tissue—shortly thereafter, he suffered organ failure and fell into a coma due to pneumonia caused by MRSA; a 54-year-old man came in days after Allen and died within hours; a 28-year-old woman was the third victim and was dead on arrival (1).

Currently, the CDC tracks only “invasive” MRSA infections—cases where the bacteria have reached the bloodstream or invaded internal organs—and 80,500 invasive MRSA cases were recorded in 2011, the most recent year of data available, which was celebrated as a significant decline from previous years. But that same year, there were nearly 460,000 hospitalizations involving a MRSA diagnosis, according to hospital billing data collected by the U.S. Agency for Healthcare Research and Quality—meaning that the CDC’s figures excluded more than 375,000 MRSA infections that were severe enough to involve hospital care (1). Further, the figures failed to include the incidents that go untreated and unreported that some experts believe could potentially range in the millions, per Clearstream CEO Jim Praechtl.

Praechtl said that the CDC’s tracking methods fail to showcase the true risk of MRSA infections, which he says are much more prevalent than the public realizes. And not only is the lack of accurate data inhibiting efforts to develop prevention strategies, due to sparse evidence on where and when most community-based MRSA cases occur, but it is also giving the public a false sense of safety, added Praechtl.

“The general public is largely unaware of the risk that MRSA poses to their health—there are strains of bacteria circulating throughout communities, and they are becoming increasingly drug-resistant and resilient, a fact which makes advanced sanitization methods and efficient antimicrobial technologies a necessity for helping to protect public safety and health,” said Praechtl.

Clearstream’s services, which have been utilized by several industries ranging from professional sports teams to healthcare facilities, are provided to the full range of stakeholders responsible for controlling the spread of infectious diseases. mPact, Clearstream’s service division, offers a two-step protective solution consisting of EPA- and FDA-registered products:

1.    mPerial® Detergent/Disinfectant provides sanitization and disinfection that eliminate a broad spectrum of bacteria, fungi and viruses, and is proven effective against, but not limited to, Norovirus (Norwalk virus), MRSA, HIV-1, and Vancomycin intermediate resistant Staphylococcus aureus (VISA). mPerial, with its grime-removing and disinfecting properties, is the first step in the mPact protocol.

2.    mPale® Antimicrobial with ÆGIS Microbe Shield® is a surface protection technology that renders offending microbes inactive, while doing so safely for people and animals. Its unique design allows the formula to bond with virtually all surfaces, and provides a non-leaching, non-toxic and environmentally-safe long-term protection.

In addition to embracing antimicrobial technology, Praechtl’s partner, Tony Daddona, encourages the public to adopt good hygiene habits to limit the risk of exposure to MRSA and other bacterial and viral contaminants that are impacting the health of Americans, specifically with regard to public areas and those which tend to be densely populated, such as gyms, grocery stores, public transportation and schools.

For increased protection, Daddona suggests that citizens should take a more proactive approach to fighting bacteria by finding out what their local public facilities are doing about containing the MRSA bacterium.

“Our goal is to be a contributing factor in the fight against MRSA and other harmful contaminants. Through our technology, we aim to eradicate harmful microorganisms and protect the surfaces that human populations come in contact with, thereby providing an additional safeguard for the public,” said Daddona.

Clearstream offers a wide range of EPA-registered and FDA-approved products and services dedicated to reducing cross-contamination on protected surfaces by harmful bacteria and viruses.

For more information about Clearstream’s products and services, visit http://www.thinkclearstream.com.

About Clearstream, LLC:

Clearstream is a multi-dimensional and diversified provider of products and services that combines multiple disciplines. Clearstream’s environmentally-safe, corrective and long-term protective solutions employ advanced antimicrobial formulations in the fight against microbial cross-contamination and surface degradation. Clearstream accomplishes its credo, “Clean, Protect, Preserve,” by matching market-driven demands and industry-specific challenges with the most highly-effective products and technical services available. Clearstream’s team of professionals brings years of wide-ranging experience together under one banner. This comprehensive mix of seasoned talent forces innovation, promotes critical concepts, develops efficiencies, and recognizes the importance of making our personal and external environments secure against the unhealthy and destructive effects caused by microbial attack. The company is based in Charlotte, North Carolina, and has partner-run operations in Florida, Texas, South Carolina and Pennsylvania. For more information, visit http://www.thinkclearstream.com.

1.Eisler, Peter. “Dangerous MRSA Bacteria Expand into Communities.” Usatoday.com. Gannett, 16 Dec. 2013. Web. 01 Apr. 2014. usatoday.com/story/news/nation/2013/12/16/mrsa-infection-community-schools-victims-doctors/3991833/.


Contact

  • Karla Jo Helms
    JoTo PR
    +1 (888) 202-4614 Ext: 802
    Email